In patients with ovarian cancer, TAP1 protein abundance was negatively correlated with survival time and significantly correlated with immune infiltration and poor prognosis [12].Therefore, there is no consistent relationship between TAP1 expression and patient prognosis in different cancer types. The gene discussed is TAP1; the disease is cancer.